Leadership
Board of Directors
Ayse McCracken, CPA MBA
President, eNNOVATE Health Ventures LLC, Advisor TMCx & Investor
Myra Davis
Senior Vice President/Chief Information and Innovation Officer, Texas Children's Hospital
Kelli Newman, APR
President, Newman & Newman, Inc
PATRICIA GAIL BRAY, PhD
President, Westlake Health Consulting in Houston and Founding Director of BridgeUp Center at the Menninger Clinic
Cheryl Stavins, RN
President, CLS Consulting, Advisor TMCx and Investor
Irene Helsinger, MBA
Managing Director, Board of Directors Newport LLC
Steering Committee
Juliet Breeze, MD
CEO, Next Level Urgent Care
Denise Castillo Rhodes, CPA
EVP and CFO, Texas Medical Center
Amanda Ebbighausen Bernal
Senior Manager, Accenture
Amanda Hammel
CIO, Memorial Hermann Health System
Susan Feigin Harris, JD
Partner, Norton Rose Fulbright
Chantell Preston
CEO, Facilities Management Group
Barbara Vilutis
Retired, EVP, Amegy Bank
Sandy Guitar
Managing Director, HX Venture Fund
Karen Hill, SVP MBA
Chief Medical Officer of Texas Children's Health Plan
Stephanie Carlton
Partner, McKinsey & Company
Heidi Schwarzwald, MD MPH
Deputy Chief Medical Officer, Aetna Medicaid
Ann Tanabe
CEO BioHouston, Inc.
Roberta Schwartz, PhD
Executive Vice President and Chief Innovation Officer, Houston Methodist Hospital
Angela A. Shippy, MD, FACP, FHM
Senior Physician Executive & Clinical Innovation Lead AWS, NP Healthcare
Leslie Wise
Principal EvidenceMatters
Senem Guney, PhD
Vice President, Language Analytics Press Ganey
Fiona Mack
Head of Jlabs @TMC Johnson & Johnson Innovation
Sarah Sossong
Vice President, Virtual Care and Winter Street Ventures for Commonwealth Care Alliance
Christy Anderson
Executive Director, Banner Innovation Group
Erin Henkel
VP of Service Design, NOCD
Terri Burke
Co-Founder and CEO, Protaryx Medical Inc. Venture Partner, Epidarex Capital
Deborah Nelson
Senior Principal Enterprise Solutions, Vizient
Deborah Gordon, EVP
Chief Administrative Officer and Chief Legal Officer, Memorial Hermann Health System
Anna Valldolid
Relationship Executive, Life Sciences, J.P. Morgan